Adaptive Insulin Delivery Systems for Niche Environments

This inventive concept adapts insulin delivery rates for specific, narrow markets or unique operational environments, such as high-altitude, disaster relief, high-security, extreme weather conditions, or remote areas, ensuring personalized and effective glucose management in diverse settings.

The original patent, 'Adjusting insulin delivery rates,' addresses the need for personalized insulin delivery. However, it lacks consideration for unique environmental factors that may impact glucose levels. This inventive concept solves the problem of inadequate insulin delivery in specialized scenarios, ensuring improved glucose control and reduced risks of hypoglycemia.

The adaptive insulin delivery system comprises a glucose measurement device, a processor, and a controller. In high-altitude environments, the system adjusts for lower air pressure and oxygen levels. In disaster relief situations, the system incorporates a fear of hypoglycemia index to prioritize insulin delivery. In high-security environments, the system employs secure communication modules to protect sensitive data. In extreme weather conditions, the system adjusts glucose measurements according to weather data. In remote areas, the system utilizes satellite communication to receive glucose data. The processor predicts multiple future blood glucose levels for different basal insulin delivery profiles, and the controller selects the optimal profile based on the predictions.

The new claims introduce novel adaptations for specific environments, which are not addressed in the original patent. The inventive step lies in the integration of environmental factors into the insulin delivery system, enabling personalized glucose management in diverse settings.

Alternative embodiments may include wearable devices, mobile applications, or cloud-based services that integrate environmental data and glucose measurements. Variations may involve different sensors, communication protocols, or algorithms for predicting glucose levels.

This inventive concept has significant commercial potential in the healthcare industry, particularly in niche markets such as adventure travel, disaster response, high-security facilities, or rural healthcare. The adaptive insulin delivery system can improve glucose management, reduce healthcare costs, and enhance quality of life for individuals with diabetes.